Anticoagulation Reversal
Articles
- Factor Xa Inhibitor-Related Intracranial Hemorrhage (FiX-ICH): Results from a Multicenter, Observational Cohort Receiving Prothrombin Complex Concentrates. (Circulation 2020)
- Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor-Associated Bleeding: A Retrospective Study. (J Intensive Care Med 2020)
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors. (N Engl J Med 2019)
- Fixed-dose 4-factor prothrombin complex concentrate: we don't know where we're going if we don't know how to get there. (J Thromb Thrombolysis 2018)
- Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. (N Engl J Med 2017)
- Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement of healthcare professionals from Neurocritical Care Society and Society of Critical Care Medicine. (Neurocrit Care 2016)
- Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016. (West J Emerg Med 2016)
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. (J Thromb Haemst 2016)
- Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. (Circulation 2013)
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate. (Circulation 2011)
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
Thrombosis/Pulmonary Embolism
Articles
- Outpatient versus inpatient treatment for acute pulmonary embolism. (Cochrane Database Syst Rev 2019)
- Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. (Cochrane Database Syst Rev 2018)
- Thrombolytic therapy for pulmonary embolism. (Cochrane Database Syst Rev 2018)
- Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. (J Am Coll Cardiol 2017)
- Fibrinolysis for patients with intermediate-risk pulmonary embolism. (N Engl J Med 2014)
- Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. (Circulation 2011)
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. (J Clin Oncol 2020)
- Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Suspected Acute Venous Thromboembolic Disease. (Ann Emerg Med 2018)
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. (Blood Adv 2018)
Guidelines
ADVERTISEMENT
Member Only
Join ASHP today to get access to the full content